Kamyar Kalantar-Zadeh M.D. to Erythropoietin
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Erythropoietin.
Connection Strength
4.505
-
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther. 2021 01; 38(1):52-75.
Score: 0.688
-
A faster decline of residual kidney function and erythropoietin stimulating agent hyporesponsiveness in incident hemodialysis patients. Hemodial Int. 2021 01; 25(1):60-70.
Score: 0.685
-
Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin. Am J Hematol. 2012 Aug; 87(8):833-6.
Score: 0.384
-
Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients. Clin Transplant. 2012 Sep-Oct; 26(5):782-91.
Score: 0.378
-
Darbepoetin alfa and chronic kidney disease. N Engl J Med. 2010 Feb 18; 362(7):654; author reply 655.
Score: 0.328
-
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008 Oct; 52(4):727-36.
Score: 0.296
-
Epoetin dosing and dialysis facility ownership. JAMA. 2007 Aug 22; 298(8):862; author reply 862-3.
Score: 0.276
-
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006 Apr; 17(4):1181-91.
Score: 0.250
-
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003 Oct; 42(4):761-73.
Score: 0.211
-
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology. Am J Nephrol. 2017; 45(3):235-247.
Score: 0.133
-
Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort. Nephrol Dial Transplant. 2017 02 01; 32(2):370-377.
Score: 0.133
-
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis. 1995 Aug; 26(2):292-9.
Score: 0.120
-
Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol. 2011 Dec; 6(12):2879-86.
Score: 0.092
-
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr. 2011 Sep; 94(3):945-54.
Score: 0.091
-
Erythropoietin in kidney disease and type 2 diabetes. N Engl J Med. 2011 01 27; 364(4):384-5; author reply 385-6.
Score: 0.087
-
Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? Nephrol News Issues. 2007 Jan; 21(1):34-8.
Score: 0.066
-
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr. 2005 Apr; 15(2):231-43.
Score: 0.058
-
Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Semin Dial. 2004 Sep-Oct; 17(5):336-41.
Score: 0.056
-
A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004 Apr; 43(4):671-84.
Score: 0.055
-
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov; 42(5):864-81.
Score: 0.053
-
Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis. 1998 Feb; 31(2):263-72.
Score: 0.036
-
New Options for Iron Supplementation in Maintenance Hemodialysis Patients. Am J Kidney Dis. 2016 Mar; 67(3):367-75.
Score: 0.031